Advanced Medical Solutions Group PLC
Company Profile
Business description
Advanced Medical Solutions Group PLC is engaged in developing, and manufacturing advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical; and Woundcare, of which Surgical segment derives maximum revenue.
Contact
Premier Park, 33 Road One
Winsford Industrial Estate
WinsfordCheshireCW7 3RT
GBRT: +44 1606863500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
1,229
Stocks News & Analysis
stocks
Overpriced ASX listed consumer electronics retailers
stocks
Nvidia and AMD: Maintain fair value estimate amid reports of Meta’s negotiations to buy Google TPUs
stocks
Alphabet: Gemini momentum and possible Meta TPU deal underscore AI capability
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,912.00 | 2.90 | 0.03% |
| CAC 40 | 8,096.43 | 70.63 | 0.88% |
| DAX 40 | 23,726.22 | 261.59 | 1.11% |
| Dow JONES (US) | 47,427.12 | 1,181.71 | 2.56% |
| FTSE 100 | 9,691.58 | 82.05 | 0.85% |
| HKSE | 26,075.93 | 147.85 | 0.57% |
| NASDAQ | 23,214.69 | 189.10 | 0.82% |
| Nikkei 225 | 50,207.47 | 648.40 | 1.31% |
| NZX 50 Index | 13,432.20 | 129.81 | -0.96% |
| S&P 500 | 6,812.61 | 46.73 | 0.69% |
| S&P/ASX 200 | 8,617.30 | 2.40 | 0.03% |
| SSE Composite Index | 3,890.05 | 25.86 | 0.67% |